MTOR and tuberous sclerosis: Using astrocytes derived from human TSC patients, an impact of the mTOR pathway on astrocytic calcium signaling and mitochondrial metabolism was suggested (Fig. 2); however, mTOR activation or S6K1 phosphorylation was not directly confirmed in these astrocytes, but assumed from the TSC mutations [82].